Lantern Pharma

(NASDAQ) LTRN

Current Price$4.17

Market Cap$53.20M

Since IPO (2020)-72%

5 Year-71%

1 Year+32%

1 Month+16%

Lantern Pharma Financials at a Glance

Market Cap

$53.20M

Revenue (TTM)

$0.00

Net Income (TTM)

-$15.91M

EPS (TTM)

-$1.45

P/E Ratio

-2.89

Dividend

$0.00

Beta (Volatility)

1.42 (Average)

Dividend

$0.00

Beta (Volatility)

1.42 (Average)

Price

$4.17

Volume

Open

$4.07

Price

$4.17

Volume

Open

$4.07

Previous Close

$4.17

Daily Range

$3.92 - $4.20

52-Week Range

$1.11 - $5.74

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

1.42 (Average)

Price

$4.17

Volume

Open

$4.07

Previous Close

$4.17

Daily Range

$3.92 - $4.20

52-Week Range

$1.11 - $5.74

Estimated Earnings Date

Aug 12, 2026

LTRN News

Lantern Pharma Narrows Loss in Q2

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lantern Pharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Panna L. Sharma

Website

www.lanternpharma.com

Headquarters

Dallas, TX 75201, US

LTRN Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-198.35%

Return on Capital

-21.13%

Return on Assets

-220.29%

Earnings Yield

-34.60%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$53.20M

Shares Outstanding

12.76M

Volume

Avg. Volume

534.07K

Financials (TTM)

Gross Profit

-$3.85K

Operating Income

-$16.61M

EBITDA

-$15.90M

Operating Cash Flow

-$15.07M

Capital Expenditure

-$567.00

Free Cash Flow

-$15.07M

Cash & ST Invst.

$6.32M

Total Debt

$59.08K

Lantern Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$3.85K

N/A

Gross Margin

0.00%

N/A

Market Cap

$53.20M

N/A

Market Cap/Employee

$2.22M

N/A

Employees

N/A

Net Income

-$3.33M

+26.6%

EBITDA

-$3.33M

+26.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$6.32M

-67.9%

Total Debt

$59.08K

-69.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$59.08K

-63.4%

Return on Assets

-2.20%

N/A

Return on Invested Capital

-4.82%

N/A

Free Cash Flow

-$3.77M

+13.8%

Operating Cash Flow

-$3.77M

+13.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LVTXLAVA Therapeutics N.V.

LVTXLAVA Therapeutics N.V.$1.74-3.87%

ELUTElutia Inc

ELUTElutia Inc$0.98+2.42%

ANVSAnnovis Bio, Inc.

ANVSAnnovis Bio, Inc.$1.86+0.00%

RNXTRenovoRx, Inc.

RNXTRenovoRx, Inc.$0.98+1.03%

TVRDTvardi Therapeutics, Inc.

TVRDTvardi Therapeutics, Inc.$1.90-0.52%

CALCCalciMedica, Inc.

CALCCalciMedica, Inc.$1.03+4.36%

BCABBioAtla, Inc.

BCABBioAtla, Inc.$4.14+8.09%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.31-0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.16+0.04%

NOKNokia

NOKNokia$13.28+0.02%

NKENike

NKENike$41.05-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$33.29-0.03%

SMCISuper Micro Computer

SMCISuper Micro Computer$29.33+0.04%

ONDSOndas

ONDSOndas$8.24+0.03%

Questions About LTRN

What is the current price of Lantern Pharma?

Lantern Pharma is trading at $4.17 per share.

What is the 52-week range for Lantern Pharma?

Over the past 52 weeks, Lantern Pharma has traded between $1.11 and $5.74.

How much debt does Lantern Pharma have?

As of the most recent reporting period, Lantern Pharma reported total debt of $59.08K.

How much cash does Lantern Pharma have on hand?

Lantern Pharma reported $4.92M in cash and cash equivalents in its most recent financial results.

What is Lantern Pharma’s dividend yield?

Lantern Pharma does not currently have a dividend yield.

Lantern Pharma

Lantern Pharma Financials at a Glance

LTRN News

Lantern Pharma Narrows Loss in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lantern Pharma

LTRN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lantern Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LTRN

What is the current price of Lantern Pharma?

What is the 52-week range for Lantern Pharma?

How much debt does Lantern Pharma have?

How much cash does Lantern Pharma have on hand?

What is Lantern Pharma’s dividend yield?

Premium Investing Services